Skip to main content
Top
Published in: Clinical Rheumatology 1/2008

01-06-2008 | Case Report

Hypertrophic cranial pachymeningitis in a patient with Cogan’s syndrome

Authors: Masaru Togashi, Atsushi Komatsuda, Rie Masai, Nobuki Maki, Takashi Hatakeyama, Hideki Wakui, Ken-ichi Sawada

Published in: Clinical Rheumatology | Special Issue 1/2008

Login to get access

Abstract

A 63-year-old man presented with chronic headache and bilateral hearing loss. A physical examination showed bilateral conjunctivitis. Circulating anti-Cogan peptide antibodies were detected by dot blot analysis. He was diagnosed as having Cogan’s syndrome (CS). Steroid therapy led to dramatic improvement of his symptoms and abnormal laboratory findings. During a tapering course of steroid therapy, he suffered from headache. An ophthalmoscopic examination revealed papillary edema. Magnetic resonance imaging of the brain showed hypertrophic cranial pachymeningitis (HCP). After steroid pulse therapy, HCP was improved. To our knowledge, this is the first case of CS complicated with HCP.
Literature
1.
go back to reference Cheson BD, Bluming AZ, Alroy J (1976) Cogan’s syndrome: a systemic vasculitis. Am J Med 60:549–555PubMedCrossRef Cheson BD, Bluming AZ, Alroy J (1976) Cogan’s syndrome: a systemic vasculitis. Am J Med 60:549–555PubMedCrossRef
2.
go back to reference Grasland A, Pouchot J, Hachulla E et al (2004) Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology 43:1007–1015PubMedCrossRef Grasland A, Pouchot J, Hachulla E et al (2004) Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology 43:1007–1015PubMedCrossRef
3.
go back to reference Lunardi C, Bason C, Leandri M et al (2002) Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet 360:915–921PubMedCrossRef Lunardi C, Bason C, Leandri M et al (2002) Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet 360:915–921PubMedCrossRef
4.
5.
go back to reference Kupersmith MJ, Martin V, Heller G et al (2004) Idiopathic hypertrophic pachymeningitis. Neurology 62:686–694PubMed Kupersmith MJ, Martin V, Heller G et al (2004) Idiopathic hypertrophic pachymeningitis. Neurology 62:686–694PubMed
6.
go back to reference Akahoshi M, Yoshimoto G, Nakashima H et al (2004) MPO-ANCA-positive Wegener’s granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod Rheumatol 14:179–183PubMedCrossRef Akahoshi M, Yoshimoto G, Nakashima H et al (2004) MPO-ANCA-positive Wegener’s granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod Rheumatol 14:179–183PubMedCrossRef
7.
go back to reference Ruiz-Sandoval JL, Bernard-Medina G, Ramos-Gómez EJ et al (2006) Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate. Acta Neurochir (Wien) 148:1011–1014CrossRef Ruiz-Sandoval JL, Bernard-Medina G, Ramos-Gómez EJ et al (2006) Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate. Acta Neurochir (Wien) 148:1011–1014CrossRef
8.
go back to reference Estivill X, Fortina P, Surrey S et al (1998) Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 351:394–398PubMedCrossRef Estivill X, Fortina P, Surrey S et al (1998) Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 351:394–398PubMedCrossRef
Metadata
Title
Hypertrophic cranial pachymeningitis in a patient with Cogan’s syndrome
Authors
Masaru Togashi
Atsushi Komatsuda
Rie Masai
Nobuki Maki
Takashi Hatakeyama
Hideki Wakui
Ken-ichi Sawada
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue Special Issue 1/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0841-0

Other articles of this Special Issue 1/2008

Clinical Rheumatology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine